Alterity Therapeutics Limited ( ATHE) - Key Metrics
ATHE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $0 | $0 | $0 | $0 |
| 2024Q2 | $0 | $0 | $0 | $0 |
| 2023Q4 | $0 | $0 | $0 | $0 |
| 2023Q2 | $0 | $0 | $0 | $0 |
| 2022Q4 | $0 | $0 | $0 | $0 |
ATHE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | -0.63 |
| 2024Q2 | ? | -0.67 |
| 2023Q4 | ? | -0.74 |
| 2023Q2 | ? | -0.75 |
| 2022Q4 | ? | -1.25 |
ATHE
Price: $4.31
52 week price:
Earnings Per Share: -0.59 USD
P/E Ratio: -5.97
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 8900
Market Capitalization: 36.7 million